Literature DB >> 8645073

Factors influencing outcome of surgery for primary aldosteronism.

O Celen1, M J O'Brien, J C Melby, R M Beazley.   

Abstract

OBJECTIVE: To identify factors that influence the outcome of surgery for primary aldosteronism.
DESIGN: A retrospective clinical series, with a mean follow-up of 106 months (range, 12-280 months), of 42 patients who underwent adrenalectomy for primary aldosteronism between the years 1970 and 1993.
SETTING: All patients were operated on at the Boston University Medical Center Hospital. PATIENTS AND INTERVENTION: We reviewed the records of 22 women and 20 men, ranging in age from 25 to 68 years, who underwent adrenalectomy for primary aldosteronism. Tests performed for preoperative classification of the adrenal pathological abnormalities included adrenal venous sampling, postural stimulation test, iodocholesterol I 131 scintigraphy, and computed tomography. MAIN OUTCOME MEASURES: The surgical outcome was classified as follows: response, normal blood pressure measurement (< 160/95 mm Hg) without medication; incomplete response, normal blood pressure measurement with medication or blood pressure measurement greater than 160/95 mm Hg despite antihypertensive treatment.
RESULTS: Twenty-five patients (60%) became normotensive following surgery. The following factors were associated with a complete response to adrenalectomy by univariate analysis: adenoma classification (odds ratio [OR] = 9.6, P = .002); preoperative response to spironolactone (OR = 8.3, P = .007); age younger than 44 years (OR = 6.2, P = .009); and duration of hypertension less than 5 years (OR = 5.1, P = .03). Response to spironolactone was predictive only in cases classified as adenoma (P = .004). Duration of hypertension showed a strong correlation with age (r = 0.62). Using stepwise logistic regression, adenoma pathological classification, response to spironolactone, and duration of hypertension less than 5 years contributed independently to a predictive model. Micronodular hyperplasia alone was associated with incomplete response. The presence of coexisting micronodular hyperplasia in patients with adenoma did not affect the odds for a complete response. Computed tomography for preoperative diagnosis of adenoma showed the same level of accuracy (75%) as that for postural stimulation test and iodocholesterol scintigraphy, but less than that for adrenal venous sampling (91%).
CONCLUSIONS: The study showed that the main determinants of a surgical cure of hypertension in primary aldosteronism were presence of adenoma and preoperative response to spironolactone. We favor computed tomography as the initial test to establish preoperative diagnosis of adenoma because of its reproducibility and high specifity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645073     DOI: 10.1001/archsurg.1996.01430180072015

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  25 in total

Review 1.  Diagnosis and treatment of primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Franco Veglio
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

2.  Laboratory investigation of primary aldosteronism.

Authors:  Michael Stowasser; Paul J Taylor; Eduardo Pimenta; Ashraf H Al-Asaly Ahmed; Richard D Gordon
Journal:  Clin Biochem Rev       Date:  2010-05

Review 3.  Primary aldosteronism.

Authors:  Richard J Auchus; Fiemu E Nwariaku
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

4.  Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia.

Authors:  Martin K Walz; Roland Gwosdz; Stephanie L Levin; Piero F Alesina; Anna-Carinna Suttorp; Klaus A Metz; Frank A Wenger; Stephan Petersenn; Klaus Mann; Kurt W Schmid
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

5.  Outcome of surgery for primary hyperaldosteronism.

Authors:  Jens Waldmann; Lisa Maurer; Julia Holler; Peter H Kann; Annette Ramaswamy; Detlef K Bartsch; Peter Langer
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

6.  Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Authors:  Yuichi Fujii; Yoshiyu Takeda; Isao Kurihara; Hiroshi Itoh; Takuyuki Katabami; Takamasa Ichijo; Norio Wada; Yui Shibayama; Takanobu Yoshimoto; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Katsutoshi Takahashi; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Hirotaka Shibata; Kohei Kamemura; Michio Otsuki; Koichi Yamamto; Atsushi Ogo; Toshihiko Yanase; Shintaro Okamura; Shozo Miyauchi; Megumi Fujita; Tomoko Suzuki; Hironobu Umakoshi; Tatsuki Ogasawara; Mika Tsuiki; Mitsuhide Naruse
Journal:  J Hum Hypertens       Date:  2019-08-28       Impact factor: 3.012

Review 7.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

8.  Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.

Authors:  Allison B Weisbrod; Richard C Webb; Aarti Mathur; Stephanie Barak; Smita Baid Abraham; Naris Nilubol; Martha Quezado; Constantine A Stratakis; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2012-10-23       Impact factor: 5.344

Review 9.  Diagnosis and management of primary aldosteronism.

Authors:  Malcolm H Wheeler; Dean A Harris
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

10.  Adrenocortical causes of hypertension.

Authors:  Andreas Moraitis; Constantine Stratakis
Journal:  Int J Hypertens       Date:  2011-03-08       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.